Decode Health Email Format
Biotechnology ResearchTennessee, United States11-50 Employees
Decode Health is a Nashville-based biotechnology research company focused on precision medicine R&D. It combines an automated analytical engine, proprietary patient data, and scientific expertise to deliver validated findings on a shorter timeline, advancing programs in molecular biomarker discovery and clinical decision support through structured, phased engagements that culminate in defined deliverables and decision gates. The company serves pharmaceutical, diagnostics, and health technology partners seeking faster paths from question to validated results with commercially structured IP and evidence packages tailored for regulatory, licensing, and payer discussions. With a portfolio spanning autoimmunity, neurodegenerative disease, oncology, infectious disease, and gastroenterology, Decode Health emphasizes a disease-agnostic architecture designed to extend into new conditions. It operates in the biotechnology research sector from its Nashville location, collaborating with large corporations, academic medical centers, and patient advocacy organizations, and has published work in peer-reviewed journals. A notable recent development is a collaboration integrating its MS biomarker program with Circular Genomics’ circular RNA platform to support earlier detection and monitoring of multiple sclerosis.